US REGULATORY RECORDS
- Matching FDA DMF subjects
- 0
- Active (A)
- 0
- Inactive (I)
- 0
FDA list cutoff:
ACTIVE PHARMACEUTICAL INGREDIENT
Research Montmorillonite API through China CDE registrations. Compare reported companies, packaging and review statuses, preview source records, then subscribe to search and export the complete available dataset.
Complete data requires an active subscription. Already subscribed? Sign in to access your data.
This Montmorillonite profile covers records named 蒙脱石. CAS 1318-93-0 identifies the reference mineral; the registry does not independently verify the CAS or grade of each material. Bentonite filings are excluded.
The supplied snapshots contain 18 Montmorillonite CDE registrations: 16 with A status and 2 with I status. No subjects containing Montmorillonite or Diosmectite were found in the FDA Q2 2026 workbook.
FDA list cutoff:
CDE export captured:
These are dated, name-selected records. The FDA result applies only to those search terms in the June 30, 2026 snapshot, not to every possible filing name or later list. Registration counts are not counts of qualified or available suppliers.
$19.00 per month
$149.00 per year
Billed $149.00 every year
This Montmorillonite profile: 18 CDE registrations. No Montmorillonite or Diosmectite subjects were found in the supplied FDA Q2 2026 snapshot.
One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product. This does not include quotations, supplier qualification or live monitoring.
CHINA REGULATORY RECORDS
Compare Montmorillonite registrations by number, reported company, product origin and review status. Open each sample to inspect its original Chinese fields, including packaging, addresses and source remarks.
16Approved or qualifying prior approval (A)
2Technical review not passed or unlinked (I)
CDE A indicates an approved or qualifying reviewed registration through one of the regulator’s stated routes. I means technical review has not been passed or the material has not been linked to a formulation registration. These meanings differ from FDA active and inactive status. Neither the status nor a reported validity date verifies present supply or batch suitability.
Free previewShowing 3 sample records of 18.
Free preview
More records available with a subscription: 15.
Montmorillonite is a clay mineral of the smectite group. EPA identifies Montmorillonite with CAS 1318-93-0. Its exchangeable cations and hydration can vary, so this profile does not assign a single molecular weight or a discrete-molecule drawing. The CDE records in this profile were selected by the reported name 蒙脱石, not by independently verified batch composition.
Reference Montmorillonite identity; not an independently confirmed CAS assignment for every registry entry.
A mineral identity does not establish the pharmaceutical specification of a supplied material.
Use these original references to check Montmorillonite identity and interpret the registry information.
The reference identity is Montmorillonite, CAS 1318-93-0, a smectite-group clay mineral. The CDE dataset contains registrations reported as 蒙脱石. A matching name is a starting point for research, not proof of a particular mineral composition or pharmaceutical specification.
Bentonite is a rock or industrial clay material composed mainly of Montmorillonite and potentially other minerals. A bentonite filing therefore does not establish a Montmorillonite API registration or an interchangeable pharmaceutical grade. Bentonite subjects are excluded from this profile.
Do not infer interchangeability from the names alone. ANSM’s French Pharmacopoeia denomination describes diosmectite as a natural hydrated aluminium-magnesium silicate in the dioctahedral smectite group, also identifying other constituents and a French deposit origin. That description does not verify the composition or specification of an individual Montmorillonite registration. Compare the applicable dossier and material specification.
The October 5, 2026 snapshot contains 18 records named exactly 蒙脱石, with 16 A entries and 2 I entries. Original company fields, packaging, addresses, dates and remarks are retained. Multiple registrations or repeated names do not establish separate qualified Montmorillonite manufacturers.
CDE A can follow joint review with an approved formulation, transfer of qualifying prior approvals, or independent review of an API equivalent to one already marketed domestically. I means technical review has not been passed or the material has not been linked to a formulation registration. These Chinese review identifiers differ from FDA DMF activity status and do not establish current Montmorillonite supply.
No. The supplied FDA Q2 2026 workbook contains no SUBJECT values matching Montmorillonite or Diosmectite, searched case-insensitively across all types and statuses. This result is limited to those names and that snapshot. Filings under other terms or in later lists have not been ruled out. FDA also states that DMFs are neither approved nor disapproved.
Use the registration number to check the current official entry, then ask the relevant party to confirm its legal role, manufacturing site, material identity, specification and supporting quality documents for your intended market. Compare those documents with the Montmorillonite material being offered. Source-listed packaging and validity dates are reported fields, not verified availability or a commercial quotation.
Free visitors can inspect Montmorillonite sample records and source references. An active personal subscription provides the complete available CDE dataset, search, status filters and CSV export through the existing product tools. It does not provide a supplier quotation, qualification decision or access to confidential dossiers. No matching FDA records are included for this profile.
Montmorillonite identity references and the two supplied registry snapshots have different scopes. Each source below identifies the evidence used for this profile.
U.S. Environmental Protection Agency
Reference identity for Montmorillonite, CAS 1318-93-0, and identifier DTXSID6051225.
“1318-93-0”
U.S. Environmental Protection Agency
CAS number displayed in the EPA ChemExpo Montmorillonite entry.
World Health Organization / International Programme on Chemical Safety
Section 2.2.1 explains the mineral terminology and variable composition relevant to this profile.
“a clay mineral of the smectite group”
World Health Organization / International Programme on Chemical Safety
EHC 231, section 2.2.1, describes montmorillonite within the definition of bentonite.
Agence nationale de sécurité du médicament et des produits de santé
The French Pharmacopoeia 2002 entry defines diosmectite by mineral composition and deposit origin; it is not evidence of equivalence for any listed batch.
“groupe des smectites dioctaédriques”
Agence nationale de sécurité du médicament et des produits de santé
Diosmectite entry, printed page 8 of the French Pharmacopoeia denomination list.
U.S. Food and Drug Administration
Montmorillonite and Diosmectite searches used the supplied Q2 workbook, sheet 2Q2026-EXCEL, with a June 30, 2026 cutoff. The official page may link to a later list.
“SUBJECT”
U.S. Food and Drug Administration
Source workbook column searched for the two substance-name terms; no matching rows were found.
U.S. Food and Drug Administration
Explains the role of a DMF and the limits of interpreting a public listing.
“Are neither approved nor disapproved.”
U.S. Food and Drug Administration
FDA statement on DMFs; an active DMF is not approval of a product or supplier.
Center for Drug Evaluation, National Medical Products Administration
Montmorillonite registrations selected from the supplied October 5, 2026 full CSV export.
“蒙脱石”
Center for Drug Evaluation, National Medical Products Administration
Exact reported substance name used to select the CDE records.
Liaoning Medical Products Administration
Official explanation of A and I identifiers and the three routes to A status.
“未通过技术审评或尚未与制剂注册进行关联的标识为“I”。”
Liaoning Medical Products Administration
The regulator explains I as material that has not passed technical review or has not been linked to a formulation registration.
Use Montmorillonite registration numbers, reported names and status explanations to guide your sourcing review. Subscribe to search, filter and export the complete available CDE records after checking the free samples.
Complete data requires an active subscription. Already subscribed? Sign in to access your data.
Send APIRFQ the Montmorillonite page address, disputed registration number and supporting source so the reported data can be checked.
Contact data support